Will a Small, Long-Shot U.S. Company End up Producing the Best Coronavirus Vaccine?
Last year, vaccine developer Novavax seemed on the brink of collapse. But today, the company is one of just seven vaccinemakers to receive funding from Operation Warp Speed.